The STORM/KEYNOTE-200 part B study (IV Cavatak & Keytruda combo in NSCLC & metastatic bladder cancer) has added some more trial sites including 2 in Australia (Melbourne & Gold Coast).
It looks like this trial is accelerating finally ..... Looking forward to the results.
https://clinicaltrials.gov/show/NCT02043665
..
Add to My Watchlist
What is My Watchlist?